Prospective follow-up data from the ProGERD study suggest that GERD is not a categorial disease

American Journal of Gastroenterology

Volumn 101, Issue 11, 2006, Pages 2457-2462

  Labenz, Joachim ^a   Nocon, Marc ^b   Lind, Tore ^c   Leodolter, Andreas ^a   Jaspersen, Daniel ^d   Meyer Sabellek, Wolfgang ^e   Stolte, Manfred ^f   Vieth, Michael ^f   Willich, Stefan N ^b   Malfertheiner, Peter ^g  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c ASTRAZENECA R AND D   (Sweden)

^d KLINIKUM FULDA   (Germany)

^e ASTRAZENECA   (United Kingdom)

^f INSTITUTE OF PATHOLOGY   (Germany)

^g OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ESOMEPRAZOLE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; ESOPHAGITIS; FEMALE; FOLLOW UP; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL BIOPSY; GASTROINTESTINAL ENDOSCOPY; HEARTBURN; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PRIORITY JOURNAL; REMISSION; TREATMENT RESPONSE;

BARRETT ESOPHAGUS; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; ESOPHAGITIS; ESOPHAGOSCOPY; FEMALE; FOLLOW-UP STUDIES; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PROSPECTIVE STUDIES;

EID: 33750520550     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2006.00829.x     Document Type: Article

References (17)

1. De Vault KR, Castell DO. Guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Arch Intern Med 1995;155:2165-72.
2. Dent J, Brun J, Fendrixck AM, et al. An evidence based appraisal of reflux disease management - the Genval workshop report. Gut 1999;44(suppl 2):S1-16.
3. Fass R, Ofman JJ. Gastroesophageal reflux disease - should we adopt a new conceptual framework? Am J Gastroenterol 2002;97:1901-9.
4. Malfertheiner P, Lind T, Willich S, et al. Prognostic influence of Barrett's oesophagus and Helicobacter pylori infection on healing of erosive gastro-oesophageal reflux disease (GORD) and symptom resolution in non-erosive GORD: Report from the ProGORD study. Gut 2005;54:746-51.
5. Kulig M, Nocon M, Vieth M, et al. Risk factors of gastroesophageal reflux disease: Methodology and first epidemiological results of the ProGERD study. J Clin Epidemiol 2004;57:580-9.
6. Lundell LR, Dent J, Bennett JR, et al. Endoscopic assessment of oesophagitis: Clinical and functional correlated and further validation of the Los Angeles classification. Gut 1999;45:172-80.
7. Labenz J, Jaspersen D, Kulig M, et al. Risk factors for erosive esophagitis: A multivariate analysis based on the ProGERD study initiative. Am J Gastroenterol 2004;99:1652-6.
8. El-Serag HB, Johansson JF. Risk factors for the severity of erosive esophagitis in Helicobacter pylori-negative patients with gastroesophageal reflux disease. Scand J Gastroenterol 2002;37:899-904.
9. Sontag SJ. Helicobacter pylori infection and reflux esophagitis in children with chronic asthma. J Clin Gastroenterol 2004;38:3-4.
10. Peitz U, Vieth M, Pross M, et al. Cardia-type metaplasia arising in the remnant esophagus after cardia resection. Gastrointest Endosc 2004;59:810-7.
11. Shaheen NJ, Crosby MA, Bozymski EM, et al. Is there publication bias in the reporting of cancer risk in Barrett's esophagus? Gastroenterology 2000;119:333-8.
12. Meining A, Stein A, Weber H, et al. Eine kritische Analyse der derzeit gängigen Überwachungsstrategie des Barrett-Ösophagus basierend auf einer retrospektiven Auswertung von 6975 Patienten. Z Gastroenterol 2005;43:P022.
13. Pace F, Porro GB. Gastroesophageal reflux disease: A typical spectrum disease (a new conceptual framework is not needed). Am J Gastroenterol 2004;99:946-9.
14. Tack J, Fass R. Review article: Approaches to endoscopic-negative reflux disease: Part of the GERD spectrum or a unique acid-related disorder? Aliment Pharmacol Ther 2004;19(suppl 1):28-34.
15. Pace F, Bollani S, Molteni P, et al. Natural history of gastro-oesophageal reflux disease without oesophagitis (NERD) - a reappraisal 10 years on. Dig Liver Dis 2004;36:111-5.
16. Isolauri J, Luostarinen M, Isolauri E, et al. Natural course of gastroesophageal reflux disease: 17-22 year follow-up of 60 patients. Am J Gastroenterol 1997;92:37-41.
17. Schindlbeck NE, Klauser AG, Berghammer G, et al. Three-year follow up of patients with gastro-oesophageal reflux disease. Gut 1992;33:1016-9.